Unknown OBSERVATIONAL NCT04254224

Scandinavian Diverticulitis Trial SCANDIV-II (SCANDIV-II)

Scandinavian Diverticulitis Trial SCANDIV II: Treatment of Acute Complicated Diverticulitis: a Prospective Observational Study

Sponsor: Centrallasarettet Västerås

Conditions Diverticulitis Colon

Interventions colon resection, stoma

Updated 7 times since 2020 Last updated: Feb 2, 2020 Started: Apr 10, 2018 Primary completion: Apr 10, 2022 Completion: Sep 10, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04254224, this observational or N/A phase trial focuses on Diverticulitis Colon and remains ongoing. Sponsored by Centrallasarettet Västerås, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Mar 2025 — Present [monthly]

Unknown
Feb 2025 — Mar 2025 [monthly]

Unknown
Oct 2024 — Feb 2025 [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — Jul 2024 [monthly]

Recruiting
Mar 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centrallasarettet Västerås
Danderyd Hospital
Mora Hospital, Landstinget Dalarna
Sahlgrenska University Hospital
Stockholm South General Hospital
University Hospital, Linkoeping
Uppsala University
Uppsala University Hospital

Data source: Uppsala University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Västerås, Sweden